Abstract
High throughput screening of our chemical library for CRTH2 antagonists provided a lead compound 1a. Initial optimization of the lead led to the discovery of a novel, potent and orally bioavailable CRTH2 antagonist 17.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have